Report Description

Forecast Period

2024-2028

Market Size (2022)

USD 3.04 Billion

CAGR (2023-2028)

6.76%

Fastest Growing Segment

Medicated segment

Largest Market

North America


Market Overview

Global Intravenous (IV) Hydration Therapy Market has valued at USD 3.04 Billion in 2022 and is anticipated to project impressive growth in the forecast period with a CAGR of 6.76% through 2028. Intravenous (IV) Hydration Therapy is a medical treatment that involves delivering fluids, electrolytes, and sometimes medications directly into a person's bloodstream through a vein. It is commonly used to address dehydration and various medical conditions. Intravenous (IV) hydration is often employed to treat moderate to severe dehydration, which can occur due to illnesses, excessive sweating, vomiting, diarrhoea, or inadequate fluid intake. IV fluids quickly replenish the body's fluid levels, helping to restore electrolyte balance and maintain proper organ function. IV hydration therapy can help manage the fluid and electrolyte imbalances that can arise from certain illnesses, such as gastroenteritis, kidney infections, and urinary tract infections. Electrolytes are essential minerals (such as sodium, potassium, calcium, and magnesium) that play a crucial role in maintaining various bodily functions, including nerve and muscle function, fluid balance, and pH regulation. IV hydration therapy can correct imbalances in electrolyte levels, which can be caused by conditions like kidney dysfunction, hormonal disorders, or severe vomiting and diarrhoea.

Key Market Drivers

Increasing Surgical Procedures Drives the Market Growth

Increasing surgical procedures drive the growth of the global Intravenous (IV) hydration therapy market primarily due to the essential role that IV hydration therapy plays in supporting patients before, during, and after surgical interventions. Surgical procedures can lead to fluid and electrolyte imbalances, making proper hydration and electrolyte management crucial for successful outcomes and patient recovery. Prior to surgery, patients often need to fast or restrict their oral fluid intake, which can lead to dehydration. IV hydration therapy is used to ensure that patients are adequately hydrated before surgery, which is important for maintaining stable blood pressure, optimal organ function, and overall patient well-being. During surgery, patients may experience fluid and electrolyte shifts due to blood loss, fluid shifts, and the effects of anaesthesia. IV hydration therapy helps maintain appropriate hydration levels and electrolyte balance, supporting the body's ability to respond to surgical stress and anaesthesia. After surgery, patients may experience nausea, vomiting, and limited oral intake, which can lead to further dehydration. IV hydration therapy is essential for supporting the recovery process, preventing complications, and facilitating the healing process. Proper hydration and electrolyte balance are key factors in reducing the risk of postoperative complications, such as infections, wound healing issues, and organ dysfunction. IV hydration therapy can help minimize these risks and improve overall patient outcomes. Adequate hydration and electrolyte balance are associated with faster healing and recovery times. IV hydration therapy can help patients regain their strength and energy more quickly after surgery, allowing them to resume normal activities sooner.

Wellness and Performance Enhancement Drives the Market Growth

The concept of Wellness and Performance Enhancement has gained significant popularity in recent years, and it has contributed to the growth of the global Intravenous (IV) hydration therapy market. This trend involves individuals seeking ways to optimize their physical and mental well-being, enhance their athletic performance, and recover more efficiently from strenuous activities. IV hydration therapy has been positioned as a potential solution to address these needs. IV hydration therapy offers a quick and efficient way to rehydrate the body, which is essential for overall well-being and optimal physical performance. Dehydration can lead to fatigue, reduced cognitive function, and decreased physical endurance. Athletes, fitness enthusiasts, and individuals with demanding lifestyles are attracted to IV hydration therapy for its ability to rapidly restore hydration levels. Strenuous physical activity and intense exercise can lead to the loss of electrolytes through sweat. IV hydration therapy provides a direct way to replenish electrolytes such as sodium, potassium, magnesium, and calcium, which are crucial for muscle function, nerve conduction, and fluid balance. Athletes and active individuals often seek ways to recover more quickly after intense workouts or competitions. IV hydration therapy can help reduce muscle soreness, inflammation, and fatigue, allowing individuals to bounce back faster and resume their training regimen. The pursuit of peak physical and cognitive performance has led individuals to explore various methods to optimize their abilities. IV hydration therapy is marketed as a means to support optimal bodily functions, mental clarity, and overall performance. IV hydration therapy can be customized to meet individual needs by adjusting the composition of fluids and nutrients based on specific goals and requirements. This personalized approach appeals to those seeking tailored solutions for wellness and performance enhancement.

Growing Aging Population Propels the Market Growth

The growing aging population is a significant driver of the global Intravenous (IV) hydration therapy market due to the increased healthcare needs and specific challenges that older adults face. As people age, their bodies may become more susceptible to dehydration and electrolyte imbalances, making IV hydration therapy an important medical intervention. Older adults often experience reduced thirst sensation, which can lead to inadequate fluid intake and an increased risk of dehydration. Dehydration in the elderly can have serious consequences, including impaired cognitive function, increased fall risk, and kidney dysfunction. IV hydration therapy can quickly address dehydration and prevent associated health complications. With age, the prevalence of chronic conditions such as kidney disease, diabetes, and cardiovascular disorders increases. These conditions can lead to fluid and electrolyte imbalances, which may require regular IV hydration therapy to manage symptoms and maintain overall health. Older adults may undergo medical procedures, surgeries, or hospitalization more frequently than younger individuals. IV hydration therapy is commonly used in hospital settings to manage fluid and electrolyte imbalances resulting from medical interventions. Older adults often take multiple medications, some of which can affect fluid and electrolyte balance. IV hydration therapy can be employed to support proper hydration and minimize the potential side effects of certain medications. Dental issues, difficulty swallowing, and age-related changes in taste and appetite can lead to reduced oral fluid and nutrient intake in the elderly. IV hydration therapy provides a direct and efficient way to deliver fluids, electrolytes, and nutrients to the body. Adequate hydration and proper electrolyte balance are essential for maintaining overall well-being and quality of life in older adults. IV hydration therapy can improve energy levels, cognitive function, and overall comfort.

 

Download Free Sample Report

Key Market Challenges

Regulatory and Legal Considerations

Regulatory and legal considerations pose significant challenges to the global Intravenous (IV) hydration therapy market due to the need to ensure patient safety, maintain quality standards, and adhere to local and international regulations governing medical practices and the administration of medical treatments. Healthcare providers who administer IV hydration therapy need to hold the appropriate licenses and certifications to perform medical procedures. These requirements vary by jurisdiction and can involve extensive training and education. Obtaining and maintaining these credentials can be time-consuming and costly. Different healthcare professionals have varying scopes of practice when it comes to administering IV therapies. Legal and regulatory frameworks may restrict who is allowed to perform IV therapy, which can impact the availability and accessibility of the treatment.

Public Perception and Education

Public perception and education present a notable challenge to the global Intravenous (IV) hydration therapy market. The way IV hydration therapy is perceived by the general public, as well as healthcare professionals, can significantly impact its acceptance, adoption, and growth. Lack of awareness, misconceptions, and misinformation can hinder the market's development. Many people may not fully understand the appropriate medical indications for IV hydration therapy. There might be confusion about when it is necessary or beneficial to receive IV fluids and nutrients, leading to overuse, underuse, or misuse of the treatment. The line between medical necessity and wellness or lifestyle use of IV hydration therapy can be blurred. Some individuals may seek IV therapy for non-medical reasons, such as hangover relief or energy enhancement. Distinguishing between medical applications and wellness trends is important for responsible use. Public perception can be influenced by the availability of scientific evidence supporting the benefits of IV hydration therapy. A lack of comprehensive clinical studies and evidence-based research on certain applications may lead to scepticism or uncertainty.

Medical Professional Expertise

Medical professional expertise poses a significant challenge to the global Intravenous (IV) hydration therapy market due to the specialized training and skills required to administer IV fluids and nutrients safely and effectively. The availability of qualified healthcare practitioners trained in IV therapy can impact the accessibility and quality of IV hydration therapy services. Administering IV fluids and nutrients requires specific training and knowledge to ensure proper technique, accurate dosing, and patient safety. Healthcare professionals need to undergo formal training and education in IV therapy, which may vary by region and specialization. There might be a shortage of healthcare practitioners with the necessary expertise in IV hydration therapy, especially in some regions or healthcare settings. This shortage can limit the availability of IV therapy services to those who need them. Different healthcare professions have varying scopes of practice and regulations regarding the administration of IV therapies. Some practitioners may not be authorized to perform certain IV procedures, which can impact patient access to these treatments. Certain medical conditions or complex patient cases require a higher level of expertise to determine appropriate IV therapy protocols. Healthcare practitioners need to accurately assess patients' needs and tailor treatments accordingly.

Key Market Trends

Rise of Wellness and Lifestyle Use

In global Intravenous (IV) Hydration Therapy market, The rise of wellness and lifestyle use is a significant trend in the global Intravenous (IV) hydration therapy market. This trend involves individuals seeking IV hydration therapy not only for medical reasons but also for general wellness, lifestyle enhancement, and performance optimization. The trend has expanded the potential consumer base beyond traditional medical indications. Wellness-conscious individuals, athletes, professionals with demanding lifestyles, and those seeking quick recovery from fatigue or exertion are exploring IV hydration therapy for its perceived benefits. The trend aligns with a growing interest in holistic health and well-being. Consumers are viewing IV hydration therapy as a complementary approach to maintaining overall health, alongside other wellness practices such as diet, exercise, and stress management. Many individuals seek IV hydration therapy to boost energy levels and combat fatigue. The treatment is believed to provide a quick and efficient way to rehydrate and replenish essential nutrients, leading to improved vitality and performance. IV hydration therapy is often marketed as a way to support the immune system, particularly during times of stress, travel, or exposure to illness. Consumers may opt for IV treatments to enhance their body's defenses and well-being. IV hydration therapy is perceived as a convenient and time-efficient method of receiving hydration and nutrients. This appeals to busy individuals who seek immediate results.

Segmental Insights

Service Insights

In 2022, the Intravenous (IV) Hydration Therapy market was dominated by the energy boosters and is predicted to continue expanding over the coming years. These products provide immediate solutions for fatigue, low energy levels, and a lack of vitality. The fast-paced lifestyles of modern society have led consumers to look for quick and convenient methods to boost their energy, and IV hydration therapy with energy-boosting formulations is positioned as a potential solution. Athletes and fitness enthusiasts often turn to energy-boosting IV therapy to enhance their performance before competitions, training sessions, or intense workouts. The immediate replenishment of essential nutrients can provide an energy boost and support endurance. The focus on wellness and lifestyle optimization has driven demand for treatments that promote vitality and overall well-being. Energy-boosting IV therapy aligns with these trends by offering a fast and efficient way to revitalize the body. The segment is projected to experience the highest compound annual growth rate (CAGR) from 2023 to 2030.

Component Insight

In 2022, the Intravenous (IV) Hydration Therapy market was dominated by the medicated segment and is predicted to continue expanding over the coming years. IV hydration therapy with medicated components is often used to treat medical conditions that require targeted interventions. For example, patients with severe dehydration, electrolyte imbalances, nutrient deficiencies, or certain acute illnesses may benefit from IV therapy with specific medications and nutrients tailored to their medical needs. The medicated segment is commonly utilized in clinical settings such as hospitals, emergency rooms, and outpatient clinics where medical professionals can administer IV therapy under appropriate medical supervision. In these settings, IV therapy with medicated components is integrated into standard medical protocols for patient care.

End-Use Industry Insights

In 2022, the Intravenous (IV) Hydration Therapy market was dominated by hospitals & clinics segment and is predicted to continue expanding over the coming years. Hospitals and clinics provide a controlled and medically supervised environment for administering IV hydration therapy. Medical professionals, including doctors and nurses, are trained to assess patient needs, determine appropriate treatment plans, and monitor patient responses during the IV therapy process. Many cases requiring IV hydration therapy are medical in nature, such as severe dehydration, electrolyte imbalances, post-surgical recovery, and management of acute illnesses. Hospitals and clinics are equipped to address these clinical indications and provide targeted medical interventions. Hospitals and clinics offer comprehensive medical care, allowing IV hydration therapy to be seamlessly integrated into a patient's overall treatment plan. This holistic approach ensures coordination with other medical interventions and therapies.

 

Download Free Sample Report

Regional Insights

The Asia Pacific region has established itself as the leader in the Global Intravenous (IV) Hydration Therapy Market. North America, particularly the United States and Canada, boasts advanced healthcare systems with well-established hospitals, clinics, and medical facilities. This infrastructure supports the delivery of IV hydration therapy services across various healthcare settings. The region has witnessed a significant demand for wellness and lifestyle services, including IV hydration therapy for purposes such as energy boost, recovery, and overall well-being. The prevalence of wellness trends and a health-conscious population contribute to the popularity of IV therapy in North America.

Recent Developments

  • A new service in Reston, Core IV Therapy, provides relief from dehydration, increases the intensity of workouts and/or recoveries, and helps restore balance to the body. The ribbon cutting ceremony for Core IV Therapy, a new business in Reston, was held on Wednesday, Feb. 12, at the company’s new location, 1900 Campus Commons Dr., in front of the Greater Reston chamber of commerce. Charles Kapur, president of the chamber, cut the ribbon.
  • In November 2020, Rejuvenated, a supplement brand based in the UK, has announced the launch of its first compostable packaging range, which will initially be used for the company’s flagship product, Collagen Shots. Rejuvenated’s compostable packaging pouches are made from a three layer laminate that is bonded to the pouches by a natural adhesive which acts in a similar way to plastic.
  • In January 2022, Braun expands its presence in Vietnam with the opening of a new factory. B. Braun marked the official opening of a new world-class Hemodialysis concentrate factory at the Thanh oai Industrial Complex, Hanoi, Vietnam.

Key Market Players

  • Core IV Therapy, LLC
  • Rejuvenated UK Ltd.
  • B. Braun Medical Inc.
  • Otsuka Pharmaceutical Co., Ltd.
  • NexGen Health Inc
  • JW Life Science Corporation
  • Amanta Healthcare Ltd
  • Baxter International Inc.
  • Drip Hydration Inc.

 By Service

By Component

By End User

By Region

  • Immune Boosters
  • Energy Boosters
  • Skin Care
  • Migraine
  • Others
  • Medicated
  • Non-medicated
  • Hospitals & Clinics
  • Wellness Centers & Spas
  • Home Healthcare
  • Others
  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East & Africa


Report Scope:

In this report, Global Intravenous (IV) Hydration Therapy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

  • Intravenous (IV) Hydration Therapy Market, By Service:

o    Immune Boosters

o    Energy Boosters

o    Skin Care

o    Migraine

o    Others

  • Intravenous (IV) Hydration Therapy Market, By Component:

o    Medicated

o    Non-medicated

  • Intravenous (IV) Hydration Therapy Market, By End-User:

o    Hospitals & Clinics

o    Wellness Centers & Spas

o    Home Healthcare

o    Others

  • Global Intravenous (IV) Hydration Therapy Market, By region:

o   North America

§  United States

§  Canada

§  Mexico

o   Asia-Pacific

§  China

§  India

§  South Korea

§  Australia

§  Japan

o   Europe

§  Germany

§  France

§  United Kingdom

§  Spain

§  Italy

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Intravenous (IV) Hydration Therapy Market.

Available Customizations:

Global Intravenous (IV) Hydration Therapy Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Global Intravenous (IV) Hydration Therapy Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.   Markets Covered

1.2.2.   Years Considered for Study

1.2.3.   Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Sources

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, Trends

4.    Voice of Customer

5.    Global Intravenous (IV) Hydration Therapy Market Outlook

5.1.  Market Size & Forecast

5.1.1.   By Value 

5.2.  Market Share & Forecast

5.2.1.   By Service (Immune Boosters, Energy Boosters, Skin Care, Migraine, Others)

5.2.2.   By Component (Medicated, Non-medicated)

5.2.3.   By End-Use Industry (Hospitals & Clinics, Wellness Centers & Spas, Home Healthcare, Others)

5.2.4.   By Company (2022)

5.2.5.   By Region

5.3.  Market Map

6.    North America Intravenous (IV) Hydration Therapy Market Outlook

6.1.  Market Size & Forecast          

6.1.1.   By Value 

6.2.  Market Share & Forecast

6.2.1.   By Service

6.2.2.   By Component

6.2.3.   By End-Use Industry

6.2.4.   By Country

6.3.  North America: Country Analysis

6.3.1.   United States Intravenous (IV) Hydration Therapy Market Outlook

6.3.1.1. Market Size & Forecast

6.3.1.1.1.               By Value

6.3.1.2. Market Share & Forecast

6.3.1.2.1.               By Service

6.3.1.2.2.               By Component

6.3.1.2.3.               By End-Use Industry

6.3.2.   Mexico Intravenous (IV) Hydration Therapy Market Outlook

6.3.2.1. Market Size & Forecast

6.3.2.1.1.               By Value

6.3.2.2. Market Share & Forecast

6.3.2.2.1.               By Service

6.3.2.2.2.               By Component

6.3.2.2.3.               By End-Use Industry

6.3.3.   Canada Intravenous (IV) Hydration Therapy Market Outlook

6.3.3.1. Market Size & Forecast

6.3.3.1.1.               By Value

6.3.3.2. Market Share & Forecast

6.3.3.2.1.               By Service

6.3.3.2.2.               By Component

6.3.3.2.3.               By End-Use Industry

7.    Europe Intravenous (IV) Hydration Therapy Market Outlook

7.1.  Market Size & Forecast          

7.1.1.   By Value 

7.2.  Market Share & Forecast

7.2.1.   By Service

7.2.2.   By Component

7.2.3.   By End-Use Industry 

7.2.4.   By Country

7.3.  Europe: Country Analysis

7.3.1.   France Intravenous (IV) Hydration Therapy Market Outlook

7.3.1.1. Market Size & Forecast

7.3.1.1.1.               By Value

7.3.1.2. Market Share & Forecast

7.3.1.2.1.               By Service

7.3.1.2.2.               By Component

7.3.1.2.3.               By End-Use Industry

7.3.2.   Germany Intravenous (IV) Hydration Therapy Market Outlook

7.3.2.1. Market Size & Forecast

7.3.2.1.1.               By Value

7.3.2.2. Market Share & Forecast

7.3.2.2.1.               By Service

7.3.2.2.2.               By Component

7.3.2.2.3.               By End-Use Industry

7.3.3.   United Kingdom Intravenous (IV) Hydration Therapy Market Outlook

7.3.3.1. Market Size & Forecast

7.3.3.1.1.               By Value

7.3.3.2. Market Share & Forecast

7.3.3.2.1.               By Service

7.3.3.2.2.               By Component

7.3.3.2.3.               By End-Use Industry

7.3.4.   Italy Intravenous (IV) Hydration Therapy Market Outlook

7.3.4.1. Market Size & Forecast

7.3.4.1.1.               By Value

7.3.4.2. Market Share & Forecast

7.3.4.2.1.               By Service

7.3.4.2.2.               By Component

7.3.4.2.3.               By End-Use Industry

7.3.5.   Spain Intravenous (IV) Hydration Therapy Market Outlook

7.3.5.1. Market Size & Forecast

7.3.5.1.1.               By Value

7.3.5.2. Market Share & Forecast

7.3.5.2.1.               By Service

7.3.5.2.2.               By Component

7.3.5.2.3.               By End-Use Industry

8.    Asia-Pacific Intravenous (IV) Hydration Therapy Market Outlook

8.1.  Market Size & Forecast          

8.1.1.   By Value 

8.2.  Market Share & Forecast

8.2.1.   By Service

8.2.2.   By Component

8.2.3.   By End-Use Industry 

8.2.4.   By Country

8.3.  Asia-Pacific: Country Analysis

8.3.1.   China Intravenous (IV) Hydration Therapy Market Outlook

8.3.1.1. Market Size & Forecast

8.3.1.1.1.               By Value

8.3.1.2. Market Share & Forecast

8.3.1.2.1.               By Service

8.3.1.2.2.               By Component

8.3.1.2.3.               By End-Use Industry

8.3.2.   India Intravenous (IV) Hydration Therapy Market Outlook

8.3.2.1. Market Size & Forecast

8.3.2.1.1.               By Value

8.3.2.2. Market Share & Forecast

8.3.2.2.1.               By Service

8.3.2.2.2.               By Component

8.3.2.2.3.               By End-Use Industry

8.3.3.   South Korea Intravenous (IV) Hydration Therapy Market Outlook

8.3.3.1. Market Size & Forecast

8.3.3.1.1.               By Value

8.3.3.2. Market Share & Forecast

8.3.3.2.1.               By Service

8.3.3.2.2.               By Component

8.3.3.2.3.               By End-Use Industry

8.3.4.   Japan Intravenous (IV) Hydration Therapy Market Outlook

8.3.4.1. Market Size & Forecast

8.3.4.1.1.               By Value

8.3.4.2. Market Share & Forecast

8.3.4.2.1.               By Service

8.3.4.2.2.               By Component

8.3.4.2.3.               By End-Use Industry

8.3.5.   Australia Intravenous (IV) Hydration Therapy Market Outlook

8.3.5.1. Market Size & Forecast

8.3.5.1.1.               By Value

8.3.5.2. Market Share & Forecast

8.3.5.2.1.               By Service

8.3.5.2.2.               By Component

8.3.5.2.3.               By End-Use Industry

9.    South America Intravenous (IV) Hydration Therapy Market Outlook

9.1.  Market Size & Forecast          

9.1.1.   By Value 

9.2.  Market Share & Forecast

9.2.1.   By Service

9.2.2.   By Component

9.2.3.   By End-Use Industry 

9.2.4.   By Country

9.3.  South America: Country Analysis

9.3.1.   Brazil Intravenous (IV) Hydration Therapy Market Outlook

9.3.1.1. Market Size & Forecast

9.3.1.1.1.               By Value

9.3.1.2. Market Share & Forecast

9.3.1.2.1.               By Service

9.3.1.2.2.               By Component

9.3.1.2.3.               By End-Use Industry

9.3.2.   Argentina Intravenous (IV) Hydration Therapy Market Outlook

9.3.2.1. Market Size & Forecast

9.3.2.1.1.               By Value

9.3.2.2. Market Share & Forecast

9.3.2.2.1.               By Service

9.3.2.2.2.               By Component

9.3.2.2.3.               By End-Use Industry

9.3.3.   Colombia Intravenous (IV) Hydration Therapy Market Outlook

9.3.3.1. Market Size & Forecast

9.3.3.1.1.               By Value

9.3.3.2. Market Share & Forecast

9.3.3.2.1.               By Service

9.3.3.2.2.               By Component

9.3.3.2.3.               By End-Use Industry

10.  Middle East and Africa Intravenous (IV) Hydration Therapy Market Outlook

10.1.              Market Size & Forecast

10.1.1.                By Value 

10.2.              Market Share & Forecast

10.2.1.                By Service

10.2.2.                By Component

10.2.3.                By End-Use Industry 

10.2.4.                By Country

10.3.              MEA: Country Analysis

10.3.1.                South Africa Intravenous (IV) Hydration Therapy Market Outlook

10.3.1.1.              Market Size & Forecast

10.3.1.1.1.             By Value

10.3.1.2.              Market Share & Forecast

10.3.1.2.1.             By Service

10.3.1.2.2.             By Component

10.3.1.2.3.             By End-Use Industry

10.3.2.                Saudi Arabia Intravenous (IV) Hydration Therapy Market Outlook

10.3.2.1.              Market Size & Forecast

10.3.2.1.1.             By Value

10.3.2.2.              Market Share & Forecast

10.3.2.2.1.             By Service

10.3.2.2.2.             By Component

10.3.2.2.3.             By End-Use Industry

10.3.3.                UAE Intravenous (IV) Hydration Therapy Market Outlook

10.3.3.1.              Market Size & Forecast

10.3.3.1.1.             By Value

10.3.3.2.              Market Share & Forecast

10.3.3.2.1.             By Service

10.3.3.2.2.             By Component

10.3.3.2.3.             By End-Use Industry

11.  Market Dynamics

11.1.              Drivers

11.2.              Challenges

12.  Market Trends & Developments

12.1.              Recent Developments

12.2.              Product Launches

12.3.              Mergers & Acquisitions

13.  PESTLE Analysis

14.  Porter’s Five Forces Analysis

14.1.              Competition in the Industry

14.2.              Potential of New Entrants

14.3.              Power of Suppliers

14.4.              Power of Customers

14.5.              Threat of Substitute Product

15.  Competitive Landscape

15.1.              Business Overview

15.2.              Company Snapshot

15.3.              Products & Services

15.4.              Financials (In case of listed companies)

15.5.              Recent Developments

15.6.              SWOT Analysis

15.6.1.  Core IV Therapy, LLC

15.6.2.  Cryojuvenate UK Ltd.

15.6.3.  B. Braun Medical Inc.

15.6.4.  Otsuka Pharmaceutical Co., Ltd.

15.6.5.  NexGen Health Inc

15.6.6.  JW Life Science Corporation

15.6.7.  Amanta Healthcare Ltd

15.6.8.  Baxter International Inc.

15.6.9.  Drip Hydration Inc

16.  Strategic Recommendations

Figures and Tables

Frequently asked questions

down-arrow

The market size of the Global Intravenous (IV) Hydration Therapy Market was estimated to be USD 3.04 billion in 2022.

down-arrow

Core IV Therapy, LLC, Cryojuvenate UK Ltd., B. Braun Medical Inc., Otsuka Pharmaceutical Co., Ltd., NexGen Health Inc, JW Life Science Corporation, Amanta Healthcare Ltd, Baxter International Inc., Drip Hydration Inc are some of the key players operating in the Global Intravenous (IV) Hydration Therapy Market.

down-arrow

Public perception and awareness and Regulatory and Legal Considerations are the major challenges faced by the Global Intravenous (IV) Hydration Therapy Market in the upcoming years.

down-arrow

Increasing surgical procedure and Wellness and Performance Enhancement is majorly driving the demand for the global Intravenous (IV) Hydration Therapy market.

profile

Sakshi Bajaal

Business Consultant
Press Release

Intravenous (IV) Hydration Therapy Market to grow with a CAGR of 6.76% through 2028

Oct, 2023

The Increasing popularity of wellness and beauty treatments are the major drivers for the Global Intravenous (IV) Hydration Therapy Market.